全文获取类型
收费全文 | 1506篇 |
免费 | 113篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 58篇 |
妇产科学 | 47篇 |
基础医学 | 133篇 |
口腔科学 | 30篇 |
临床医学 | 266篇 |
内科学 | 170篇 |
皮肤病学 | 14篇 |
神经病学 | 36篇 |
特种医学 | 138篇 |
外科学 | 171篇 |
综合类 | 64篇 |
预防医学 | 125篇 |
眼科学 | 79篇 |
药学 | 91篇 |
肿瘤学 | 165篇 |
出版年
2021年 | 17篇 |
2020年 | 11篇 |
2019年 | 26篇 |
2018年 | 22篇 |
2017年 | 29篇 |
2016年 | 24篇 |
2015年 | 32篇 |
2014年 | 56篇 |
2013年 | 41篇 |
2012年 | 53篇 |
2011年 | 52篇 |
2010年 | 34篇 |
2009年 | 45篇 |
2008年 | 44篇 |
2007年 | 56篇 |
2006年 | 61篇 |
2005年 | 54篇 |
2004年 | 59篇 |
2003年 | 37篇 |
2002年 | 55篇 |
2001年 | 73篇 |
2000年 | 59篇 |
1999年 | 44篇 |
1998年 | 38篇 |
1997年 | 42篇 |
1996年 | 36篇 |
1995年 | 29篇 |
1994年 | 36篇 |
1993年 | 19篇 |
1992年 | 61篇 |
1991年 | 38篇 |
1990年 | 31篇 |
1989年 | 38篇 |
1988年 | 29篇 |
1987年 | 28篇 |
1986年 | 33篇 |
1985年 | 24篇 |
1984年 | 19篇 |
1983年 | 19篇 |
1982年 | 13篇 |
1980年 | 8篇 |
1979年 | 5篇 |
1978年 | 10篇 |
1977年 | 5篇 |
1976年 | 11篇 |
1975年 | 7篇 |
1973年 | 4篇 |
1971年 | 4篇 |
1968年 | 5篇 |
1967年 | 8篇 |
排序方式: 共有1622条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
The appearance of an acute effusion in a well-pneumatized temporal bone directs attention to the nasopharynx and skull base. Two patients are described in whom dehiscence of the temporomandibular joint allowed herniation of the contents of the joint posteromedically, where they obstructed the middle ear entrance of the eustachian tube, the protympanum. This is, to the authors' knowledge, a previously unreported cause of an acute middle ear and mastoid effusion. 相似文献
6.
Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand
PA Crock JD McKenzie AM Nicoll NJ Howard W Cutfield LK Shield G Byrne 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(4):381-386
Benign intracranial hypertension (BIH) is reported in three children from Australia and one from New Zealand, who were being treated with recombinant human growth hormone (rhGH). Three males and one female, aged between 10.5 and 14.2 y, developed intracranial hypertension within 2 weeks to 3 months of starting treatment. A national database, OZGROW, has been prospectively collecting data on all 3332 children treated with rhGH in Australia and New Zealand from January 1986 to 1996. The incidence of BIH in children treated with growth hormone (GH) is small, 1.2 per 1000 cases overall, but appears to be greater with biochemical GHD (<10IUml -1 ), i.e. 6.5/1000 (3 in 465 cases), relative risk 18.4, 95% confidence interval 1.9-176.1, than in all other children on the database. The incidence in patients with Turner's syndrome was 2.3/1000 (1 in 428 cases). No cases in patients with partial GHD (10–20 IUml -1 ) or chronic renal failure were identified. Possible causative mechanisms are discussed. The authors'practice is now to start GH replacement at less than the usual recommended dose of 14IUm-2 week-1 in those children considered to be at high risk of developing BIH. Ophthalmological evaluation is recommended for children before and during the first few months following commencement of rhGH therapy and is mandatory in the event of peripheral or facial oedema, persistent headaches, vomiting or visual symptoms. The absence of papilledema does not exclude the diagnosis. 相似文献
7.
8.
9.
10.
F M Muggia E LePoidevin S Jeffers C Russell W Boswell C P Morrow J Curtin J Schlaerth 《Annals of oncology》1992,3(2):149-154
Nineteen patients with ovarian cancer and minimal residual or persistent disease who were treated with cisplatin or carboplatin-based intraperitoneal (IP) regimens had distribution studies of IP contrast and computerized tomography prior to and during treatment. The distribution pattern was assessed retrospectively and scored for the presence of contrast in each of eight regions: the under surface of right and left diaphragms, the right and left paracolic gutters, the lesser omental sac, the intramesenteric region and the true and false pelvis. Assigning a point to each region with adequate distribution, we classified 10 patients to an excellent pattern (greater than or equal to 7 of 8 regions), 6 to a good pattern (5 to less than 7 regions), and 3 to an inadequate distribution pattern (less than 5 regions). Serial studies were performed in 8 patients after more than 4 cycles of IP therapy. In these patients, all of whom were tolerating treatment without progression, the distribution remained virtually unchanged for those with excellent distribution. One of three with good distribution manifested inadequate distribution on repeat study, and one of two with inadequate distribution improved to show a good pattern. In this small study there was no correlation of distribution patterns with plasma CA-125 at onset of IP treatment and prior surgical procedures or placement of the catheter tip. However, three patients with unsatisfactory patterns had procedures consisting of catheter placement only rather than formal reassessment laparotomies for ovarian cancer. Since satisfactory IP distribution may be required for obtaining a therapeutic advantage from IP therapy, methods for its assessment must be developed.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献